These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 28976897
1. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus. Caprnda M, Mesarosova D, Ortega PF, Krahulec B, Egom E, Rodrigo L, Kruzliak P, Mozos I, Gaspar L. Folia Med (Plovdiv); 2017 Sep 01; 59(3):270-278. PubMed ID: 28976897 [Abstract] [Full Text] [Related]
2. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardoso CRL, Leite NC, Moram CBM, Salles GF. Cardiovasc Diabetol; 2018 Feb 24; 17(1):33. PubMed ID: 29477146 [Abstract] [Full Text] [Related]
5. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients. Teliti M, Cogni G, Sacchi L, Dagliati A, Marini S, Tibollo V, De Cata P, Bellazzi R, Chiovato L. Diab Vasc Dis Res; 2018 Sep 24; 15(5):424-432. PubMed ID: 29911415 [Abstract] [Full Text] [Related]
6. Association between short-term glucose fluctuations and cognition in patients with acute ischemic stroke complicated by type 2 diabetes mellitus. Zhou R, Wei C, Zhao M, Sun L. J Nutr Health Aging; 2024 Jul 24; 28(7):100252. PubMed ID: 38692207 [Abstract] [Full Text] [Related]
7. Significance of Glycemic Variability in Diabetes Mellitus. Kusunoki Y, Konishi K, Tsunoda T, Koyama H. Intern Med; 2022 Feb 01; 61(3):281-290. PubMed ID: 34544956 [Abstract] [Full Text] [Related]
8. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Khunti K, DISCOVER investigators. Cardiovasc Diabetol; 2018 Nov 28; 17(1):150. PubMed ID: 30486889 [Abstract] [Full Text] [Related]
15. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study. Borgharkar SS, Das SS. BMJ Open Diabetes Res Care; 2019 Nov 28; 7(1):e000654. PubMed ID: 31413840 [Abstract] [Full Text] [Related]
16. Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c. Tang X, Li S, Wang Y, Wang M, Yin Q, Mu P, Lin S, Qian X, Ye X, Chen Y. Clin Chim Acta; 2016 Oct 01; 461():146-50. PubMed ID: 27502250 [Abstract] [Full Text] [Related]
17. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes. Mi SH, Su G, Li Z, Yang HX, Zheng H, Tao H, Zhou Y, Tian L. Chin Med J (Engl); 2012 Jan 01; 125(1):38-43. PubMed ID: 22340463 [Abstract] [Full Text] [Related]
18. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes. Yang CY, Su PF, Hung JY, Ou HT, Kuo S. Cardiovasc Diabetol; 2020 Jul 06; 19(1):105. PubMed ID: 32631323 [Abstract] [Full Text] [Related]